advertisement
Stamer WD 20
Showing records 1 to 20 | Display all abstracts from Stamer WD92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Cassidy PS
Molecular therapy. Methods & clinical development 2021; 20: 86-94
92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Li G
eLife 2021; 10:
92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Kelly RA
Molecular therapy. Methods & clinical development 2021; 20: 86-94
92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Lee C
eLife 2021; 10:
92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Reina-Torres E
Molecular therapy. Methods & clinical development 2021; 20: 86-94
92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Read AT; Wang K
eLife 2021; 10:
92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Sherwood JM; Humphries MM
Molecular therapy. Methods & clinical development 2021; 20: 86-94
92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Ha J
eLife 2021; 10:
92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Kiang AS
Molecular therapy. Methods & clinical development 2021; 20: 86-94
92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Kuhn M; Navarro I
eLife 2021; 10:
92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Farrar GJ; O'Brien C
Molecular therapy. Methods & clinical development 2021; 20: 86-94
92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Cui J; Young K
eLife 2021; 10:
92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Campbell M
Molecular therapy. Methods & clinical development 2021; 20: 86-94
92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Gorijavolu R
eLife 2021; 10:
92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Stamer WD; Overby DR
Molecular therapy. Methods & clinical development 2021; 20: 86-94
92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Sulchek T; Kopczynski C
eLife 2021; 10:
92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Humphries P
Molecular therapy. Methods & clinical development 2021; 20: 86-94
92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Farsiu S
eLife 2021; 10:
92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
O'Callaghan J
Molecular therapy. Methods & clinical development 2021; 20: 86-94
92680 Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis
Samples J; Challa P; Ethier CR; Stamer WD
eLife 2021; 10:
